April 25, 2023 02:07 PM EDT
FDA+
Manufacturing

Sun Phar­ma tem­porar­i­ly halts ship­ments from man­u­fac­tur­ing plant af­ter FDA let­ter

Tyler Patchen

News Reporter

Sun Phar­ma is paus­ing pro­duc­tion at one of its plants in In­dia af­ter fac­ing scruti­ny by US reg­u­la­tors over nec­es­sary cor­rec­tive work.

In a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

Ther­mo Fish­er buck­les up for US-Chi­na trade war, bud­gets $2B to ease im­pact

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times